AP747A - Pharmaceutical compositions in the form of a tablet containing famciclovir. - Google Patents

Pharmaceutical compositions in the form of a tablet containing famciclovir. Download PDF

Info

Publication number
AP747A
AP747A APAP/P/1997/000911A AP9700911A AP747A AP 747 A AP747 A AP 747A AP 9700911 A AP9700911 A AP 9700911A AP 747 A AP747 A AP 747A
Authority
AP
ARIPO
Prior art keywords
famciclovir
tablet
percentage
lactose
pharmaceutical
Prior art date
Application number
APAP/P/1997/000911A
Other languages
English (en)
Other versions
AP9700911A0 (en
Inventor
Michael John Greenway
Jennifer Mary Slater
Original Assignee
Novartis Int Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Int Pharmaceutical Ltd filed Critical Novartis Int Pharmaceutical Ltd
Publication of AP9700911A0 publication Critical patent/AP9700911A0/xx
Application granted granted Critical
Publication of AP747A publication Critical patent/AP747A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
APAP/P/1997/000911A 1996-01-16 1997-01-02 Pharmaceutical compositions in the form of a tablet containing famciclovir. AP747A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (2)

Publication Number Publication Date
AP9700911A0 AP9700911A0 (en) 1997-01-31
AP747A true AP747A (en) 1999-05-03

Family

ID=10787105

Family Applications (2)

Application Number Title Priority Date Filing Date
APAP/P/1997/000911A AP747A (en) 1996-01-16 1997-01-02 Pharmaceutical compositions in the form of a tablet containing famciclovir.
APAP/P/1998/001298A AP1114A (en) 1996-01-16 1997-01-13 Indole compounda as anti-inflammatory/analgesic agents.

Family Applications After (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001298A AP1114A (en) 1996-01-16 1997-01-13 Indole compounda as anti-inflammatory/analgesic agents.

Country Status (38)

Country Link
US (1) US6765007B1 (hu)
EP (1) EP0874632B1 (hu)
JP (2) JP4711360B2 (hu)
KR (1) KR100338829B1 (hu)
CN (1) CN1132582C (hu)
AP (2) AP747A (hu)
AR (1) AR005456A1 (hu)
AT (1) ATE220910T1 (hu)
AU (1) AU713090B2 (hu)
BG (1) BG63488B1 (hu)
BR (1) BR9706982A (hu)
CY (1) CY2390B1 (hu)
CZ (1) CZ287205B6 (hu)
DE (1) DE69714215T2 (hu)
DK (1) DK0874632T3 (hu)
DZ (1) DZ2159A1 (hu)
EA (1) EA001946B1 (hu)
EG (1) EG23684A (hu)
ES (1) ES2180922T3 (hu)
GB (1) GB9600847D0 (hu)
HK (1) HK1016473A1 (hu)
HU (1) HU225472B1 (hu)
IL (1) IL124913A0 (hu)
MX (1) MX9805713A (hu)
MY (1) MY127527A (hu)
NO (1) NO315689B1 (hu)
NZ (1) NZ326769A (hu)
OA (1) OA10812A (hu)
PE (1) PE35498A1 (hu)
PL (1) PL187291B1 (hu)
PT (1) PT874632E (hu)
SK (1) SK282132B6 (hu)
TR (1) TR199800954T2 (hu)
TW (1) TW434016B (hu)
UA (1) UA63897C2 (hu)
UY (2) UY24437A1 (hu)
WO (1) WO1997025990A1 (hu)
ZA (1) ZA97310B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
ES2401008T3 (es) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Comprimidos farmacéuticos sólidos para dispositivos implantables para la administración de fármacos
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671970A1 (fr) * 1991-01-30 1992-07-31 Wellcome Found Comprimes dispersables dans l'eau.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
CA2103050A1 (en) 1991-05-15 1992-11-16 Yung-Chi Cheng Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671970A1 (fr) * 1991-01-30 1992-07-31 Wellcome Found Comprimes dispersables dans l'eau.

Also Published As

Publication number Publication date
HUP9901021A3 (en) 2000-08-28
GB9600847D0 (en) 1996-03-20
OA10812A (en) 2003-01-29
TW434016B (en) 2001-05-16
NZ326769A (en) 2000-05-26
BG63488B1 (bg) 2002-03-29
PE35498A1 (es) 1998-08-07
UY24556A1 (es) 2001-08-27
CN1132582C (zh) 2003-12-31
AP1114A (en) 2002-10-18
UY24437A1 (es) 1997-06-06
JP2000503311A (ja) 2000-03-21
IL124913A0 (en) 1999-01-26
BR9706982A (pt) 1999-07-20
TR199800954T2 (xx) 1998-10-21
EG23684A (en) 2007-05-09
ATE220910T1 (de) 2002-08-15
DE69714215T2 (de) 2003-01-23
AP9801298A0 (en) 1998-09-30
CN1208350A (zh) 1999-02-17
CY2390B1 (en) 2004-09-10
CZ287205B6 (en) 2000-10-11
AU1541897A (en) 1997-08-11
AP9700911A0 (en) 1997-01-31
US6765007B1 (en) 2004-07-20
HK1016473A1 (en) 1999-11-05
PL187291B1 (pl) 2004-06-30
BG102638A (en) 1999-07-30
EA199800573A1 (ru) 1999-02-25
SK95698A3 (en) 1999-01-11
NO983259D0 (no) 1998-07-15
CZ225498A3 (cs) 1998-12-16
EP0874632B1 (en) 2002-07-24
ES2180922T3 (es) 2003-02-16
KR19990077229A (ko) 1999-10-25
SK282132B6 (sk) 2001-11-06
NO983259L (no) 1998-07-15
WO1997025990A1 (en) 1997-07-24
DK0874632T3 (da) 2002-11-11
EP0874632A1 (en) 1998-11-04
NO315689B1 (no) 2003-10-13
UA63897C2 (en) 2004-02-16
AR005456A1 (es) 1999-06-23
EA001946B1 (ru) 2001-10-22
JP4711360B2 (ja) 2011-06-29
ZA97310B (en) 1997-10-23
MX9805713A (es) 1998-10-31
AU713090B2 (en) 1999-11-25
HUP9901021A2 (hu) 1999-08-30
DZ2159A1 (fr) 2002-12-01
HU225472B1 (en) 2006-12-28
PL327922A1 (en) 1999-01-04
DE69714215D1 (de) 2002-08-29
PT874632E (pt) 2002-10-31
MY127527A (en) 2006-12-29
JP2009091362A (ja) 2009-04-30
KR100338829B1 (ko) 2002-07-18

Similar Documents

Publication Publication Date Title
EP2729130B1 (en) Darunavir combination formulations
US20070172521A1 (en) Levetiracetam formulations and methods for their manufacture
EP1043984A1 (en) Pharmaceutical compositions containing bupropion hydrochloride and an inorganic acid stabilizer
JP2009091362A6 (ja) 高含量ファムシクロビル錠剤
AP747A (en) Pharmaceutical compositions in the form of a tablet containing famciclovir.
US20060147519A1 (en) Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US3891755A (en) Dosage formulation for erythromycin cetyl sulfate
CA2240462C (en) High-content famciclovir tablets
EP1501521B1 (en) Long acting compositions comprising zidovudine and/or lamivudine
JP2009538905A (ja) 感湿性薬物を含んで成る安定性製剤及びその製造方法
US20020183308A1 (en) Benazepril Hydrochloride tablet formulations
CN117482057B (zh) 一种稳定的盐酸格拉司琼片及其制备方法
KR20040018314A (ko) 게피론을 함유하는 경구 투여용 연장 방출형 제제
CN115843243A (zh) 盐酸鲁拉西酮组合物及其制备方法
EP3372227A1 (en) Tablet formulation of adefovir dipivoxil
CN116687875A (zh) 盐酸优克那非药物组合物及其制备方法和用途
JP2020193229A (ja) 経口固形組成物、その製造方法、及びその製造方法によって得られた経口用錠剤
JPH06227995A (ja) 安定化された固型製剤
TR2024008321T2 (tr) Etken madde olarak masi̇tentan ve di̇ğer i̇lgi̇li̇ yardimci maddeleri̇ i̇çeren farmasöti̇k bi̇leşi̇mler